FDA Adverse Event Malfunction Summary report: N

CD2257-40Q FORTIFY ASSURA DR ICD_IDE_US

MDR report key: 13336865 · Received January 24, 2022

Report

Report Number
2017865-2022-01755
Event Type
Malfunction
Date Received
January 24, 2022
Date of Event
January 7, 2022
Report Date
April 13, 2022
Manufacturer
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
Product Code
NVZ
UDI-DI
05414734505550
PMA / PMN Number
P910023
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

RELATED MANUFACTURER REPORT NUMBER ON TENDRIL SDX ATRIAL LEAD: 2017865-2020-17758.

Description of Event or Problem · 0

IT WAS REPORTED THAT ATRIAL OVERSENSING SEEN AS ATRIAL TACHYCARDIA/ATRIAL FIBRILLATION EPISODES WERE OBSERVED IN REMOTE TRANSMISSIONS. PROGRAMMING RECOMMENDATIONS TO CONSIDER DECREASING THE ATRIAL SENSITIVITY WERE MADE. THERE WERE NO REPORTED PATIENT CONSEQUENCES.

Description of Event or Problem · 0

RELATED MANUFACTURER REPORT NUMBER: 2017865-2020-17758. NEW INFORMATION RECEIVED NOTES THE ORIGINAL EVENT WAS DUE TO A KNOWN ATRIAL LEAD NOISE WITH PACING INHIBITION ISSUE OBSERVED IN 2020. THE ATRIAL LEAD WAS LEADING TO OVERSENSING SEEN ON ATRIAL FIBRILLATION AND ATRIAL TACHYCARDIA EPISODES. PROGRAMMING CHANGES WERE MADE. THERE HAD BEEN NO ISSUES SINCE THE PROGRAMING CHANGES WERE COMPLETED AT THE END OF JAN, 2022. THE PATIENT WAS DOING WELL AND HAD REPORTED NO ISSUES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
614752 CD2257-40Q FORTIFY ASSURA DR ICD_IDE_US IMPLANTABLE CARDIOVERTER DEFIBRILLATOR NVZ ST. JUDE MEDICAL, INC.(CRM-SYLMAR) CD2257-40Q 3862981 05414734505550

Patients

Seq Age Sex Outcome Treatment
1 71 YR Male DURATA ACTIVE| TENDRIL SDX| TENDRIL SDX LEAD